Introduction to the first oral dose therapeutic for pediatric myopia control
Meet us at
7-MX : For the future of every childs vision.
Theialife is an innovative biopharmaceutical company focused on the discovery and development of first-in-class drug targeting Myopia.
Research & Development
Bioplus Life Sciences is research driven company, continually evolving and aspires to improve products and service quality through the utilization of the latest technology.
Stay updated
on our latest
news & articles.
January 30, 2025
Bioplus Secures Regulatory Approval from EFSA for Algal DHA in Infant Formula
Bioplus Life Sciences, a pioneer in biotechnology and nutrition, has achieved a significant milestone by securing EFSA (European Food Safety Authority) approval for the use of its algal DHA oil and powder in infant formula.
January 21, 2025
Bioplus Life sciences Chairman Sundeep Aurora featured on CNA News, Singapore
Bioplus chairman Sundeep Aurora shares his perspective on the impact of Trump 2.0 on the Indian Pharma industry & Bioplus' latest drug for pediatric myopia
November 23, 2023
Dr. Trier with Prof. Zeng, a renowned myopia researcher from China, at the EVER 2023 conference in València, Spain, October 26-28
At the EVER meeting in València, Spain, Dr. Klaus Trier was invited to talk at the myopia control session. Dr. Trier presented the latest analysis of data from 757 myopic children demonstrating high efficacy of 7-MX.
Our Businesses
